Forbes James D 4

What Happened
James D. Forbes, a director of DENTSPLY SIRONA Inc. (XRAY), was awarded 28,887 shares via a grant reported on Form 4. The filing lists the acquisition as code "A" (award/grant) at a reported price of $0.00 (total shown $0), and the award consists entirely of Restricted Stock Units (RSUs) that will vest in full one year from the grant date. This is a compensation-related grant, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-05 (filed two days after the transaction).
• Transaction type/code: A (Grant/Award); 28,887 RSUs granted; reported price $0.00 (total $0 on Form 4).
• Vesting/footnote: Footnote F1 — award consists entirely of RSUs that vest in full one year from grant date (restrictions lapse at that time).
• Shares owned after transaction: Not specified in the provided filing summary.
• No 10b5-1 plan, sale, exercise, or tax-withholding details disclosed in this filing.

Context: RSU grants are a form of compensation and do not indicate an immediate cash purchase or sale. Value to the holder will depend on DENTSPLY SIRONA’s stock price when the RSUs vest (one year from the grant). This appears to be a routine director compensation award rather than a trading signal.